Zachary L Watson
8PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.Lily L Nguyen, Zachary L Watson, Raquel Ortega
|Jun 12, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.Lily L Nguyen, Zachary L Watson, Raquel Ortega
|May 07, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.Lily L Nguyen, Zachary L Watson, Raquel Ortega
|Jul 26, 2023
Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma.Benjamin G Bitler, Courtney A Bailey, Tomomi M Yamamoto
|May 27, 2023
Novel chromobox 2 inhibitory peptide decreases tumor progression.Lindsay W Brubaker, Donald S Backos, Vu T Nguyen
|Mar 22, 2020
Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression.Brandon T Sawyer, Lubna Qamar, Tomomi M Yamamoto
Pageof 2
Frequent Collaborators
4 joint publications
Benjamin G Bitler
3 joint publications
Courtney A Bailey
3 joint publications
Francis To
3 joint publications
Tomomi M Yamamoto
3 joint publications
Abigail D Jeong
3 joint publications
Ritsuko Iwanaga
3 joint publications
Lily L Nguyen
3 joint publications
Raquel Ortega
3 joint publications
Elizabeth R Woodruff
3 joint publications
Kimberly R Jordan
